HOLMLUND JON T 4
4 · Galera Therapeutics, Inc. · Filed Oct 28, 2020
Insider Transaction Report
Form 4
HOLMLUND JON T
Chief Medical Officer
Transactions
- Sale
Common Stock
2020-10-26$15.00/sh−2,244$33,660→ 0 total - Exercise/Conversion
Stock Option
2020-10-26−2,244→ 108,898 totalExercise: $2.43Exp: 2026-03-31→ Common Stock (2,244 underlying) - Exercise/Conversion
Common Stock
2020-10-26$2.43/sh+2,244$5,453→ 2,244 total
Footnotes (2)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2019.
- [F2]The option has fully vested and is currently exercisable.